Skip to content
10-Q

Quarterly Report

Lazuriton Nano Biotechnology (U.S.A.) Inc.

0001640334-21-002385

← back to feed
Filed
Sep 27, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2021 · Mar 31, 2021 100M sh
Cash And Equivalents Q1 2021 · Mar 31, 2021 $1.35K
Cash And Equivalents Q1 2021 · Dec 31, 2020 $1.35K
Cash And Equivalents Q1 2021 · Mar 31, 2020 $1.35K
Cash And Equivalents Q1 2021 · Dec 31, 2019 $1.35K
Current Liabilities Q1 2021 · Mar 31, 2021 $332.08K
Current Liabilities Q1 2021 · Dec 31, 2020 $321.13K
Total Liabilities Q1 2021 · Mar 31, 2021 $332.08K
Total Liabilities Q1 2021 · Dec 31, 2020 $321.13K
Current Assets Q1 2021 · Mar 31, 2021 $1.35K
Current Assets Q1 2021 · Dec 31, 2020 $1.35K
Total Assets Q1 2021 · Mar 31, 2021 $1.35K
Total Assets Q1 2021 · Dec 31, 2020 $1.35K
Operating Cash Flow Q1 2021 · Mar 31, 2020 $0
Stockholders Equity Q1 2021 · Mar 31, 2020 −$279.99K
Stockholders Equity Q1 2021 · Dec 31, 2019 −$268.54K
Sga Expense Q1 2021 · Mar 31, 2020 $11.45K
Net Income Q1 2021 · Mar 31, 2020 −$11.45K
Operating Income Q1 2021 · Mar 31, 2020 −$11.45K
Revenue Q1 2021 · Mar 31, 2020 $0